Spinaci S, Arecco L, Anedda A, Martino L, Firpo E, Ghilli M
J Pers Med. 2025; 15(2).
PMID: 39997343
PMC: 11856642.
DOI: 10.3390/jpm15020066.
Deshmukh V, Sardeshmukh S, Kulkarni A, Gupta V, Gujar S, Sardeshmukh B
J Ayurveda Integr Med. 2025; 16(1):100982.
PMID: 39864308
PMC: 11802355.
DOI: 10.1016/j.jaim.2024.100982.
Sajdlowska J, Fawole F, Patel A, Radwan N, Yang J, Christian D
J Surg Case Rep. 2024; 2025(1):rjae820.
PMID: 39726572
PMC: 11670770.
DOI: 10.1093/jscr/rjae820.
Pirvu A, Cappelleri A, Sala L, Banco B, Giudice C, Stefanello D
Vet Res Commun. 2024; 48(6):4021-4028.
PMID: 39340734
PMC: 11538189.
DOI: 10.1007/s11259-024-10553-3.
McGrath J, Rhatigan D, Donahue D, Fannin M, Lawson N
Cureus. 2024; 16(8):e66216.
PMID: 39233942
PMC: 11374429.
DOI: 10.7759/cureus.66216.
Male Breast Cancer: Current Scenario and Future Perspectives.
Chidambaram A, Prabhakaran R, Sivasamy S, Kanagasabai T, Thekkumalai M, Singh A
Technol Cancer Res Treat. 2024; 23:15330338241261836.
PMID: 39043043
PMC: 11271170.
DOI: 10.1177/15330338241261836.
Generalization-a key challenge for responsible AI in patient-facing clinical applications.
Goetz L, Seedat N, Vandersluis R, van der Schaar M
NPJ Digit Med. 2024; 7(1):126.
PMID: 38773304
PMC: 11109198.
DOI: 10.1038/s41746-024-01127-3.
Stem cells derived exosomes as biological nano carriers for VCR sulfate for treating breast cancer stem cells.
Farouk A, Aref A, Fathy B, Abdallah A
Sci Rep. 2024; 14(1):10964.
PMID: 38744871
PMC: 11094037.
DOI: 10.1038/s41598-024-59736-7.
Clinicopathological Features and Treatment Outcomes of Male Breast Cancer in Pakistani Population: A 10-Year Retrospective Cross-Sectional Study.
Khalid I, Sarwar A, Khalid H, Sajjad B, Rehman B, Parvaiz M
Breast Cancer (Auckl). 2024; 18:11782234241233120.
PMID: 38370290
PMC: 10874586.
DOI: 10.1177/11782234241233120.
Clinicopathological analysis of 38 male patients diagnosed with breast cancer.
Sahin S, Balci S, Guler G, Altundag K
Breast Dis. 2024; 43(1):1-8.
PMID: 38363600
PMC: 10894578.
DOI: 10.3233/BD-230050.
Encapsulated Rose Bengal Enhances the Photodynamic Treatment of Triple-Negative Breast Cancer Cells.
Uddin M, Bekmukhametova A, Antony A, Barman S, Houang J, Wu M
Molecules. 2024; 29(2).
PMID: 38276623
PMC: 10820979.
DOI: 10.3390/molecules29020546.
Thyroid gland: a rare site of metastasis.
Orlandi A, Alcaraz G, Bielski L, Brenta G, Jozami L, Cavallo A
Endocrine. 2024; 84(2):607-614.
PMID: 38224445
DOI: 10.1007/s12020-023-03626-x.
Demographics, Characteristics, and Outcomes of Male Breast Cancer Patients at the Methodist Health System, Dallas, USA.
Nong H, Eastwood D, Rodriguez K, Puri V
Cureus. 2023; 15(11):e49394.
PMID: 38146568
PMC: 10749682.
DOI: 10.7759/cureus.49394.
Proton Therapy in the Treatment of Men with Breast Cancer.
Bradley J, Gracie J, Vega R, Brooks E, Burchianti T, Oladeru O
Int J Part Ther. 2023; 10(2):94-104.
PMID: 38075485
PMC: 10698632.
DOI: 10.14338/IJPT-23-00007.1.
Male breast cancer: Report of two cases with bloody nipple discharge.
McFarland B, Luo A, Wang X
Radiol Case Rep. 2023; 18(9):3323-3330.
PMID: 37520394
PMC: 10371794.
DOI: 10.1016/j.radcr.2023.07.001.
Characteristics and Outcomes in Cases of US Male Patients with Metastatic Breast Cancer Receiving Abemaciclib in Routine Clinical Practice.
Ring A, Karuturi M, Smyth E, Lokhandwala T, Sheffield K, Willey J
Adv Ther. 2023; 40(5):2515-2523.
PMID: 36995468
PMC: 10129913.
DOI: 10.1007/s12325-023-02471-8.
Ten-Year Survival of Breast Cancer in Iran: A National Study (Retrospective Cohort Study).
Akbari M, Akbari A, Khayamzadeh M, Salmanian R, Akbari M
Breast Care (Basel). 2023; 18(1):12-21.
PMID: 36876173
PMC: 9982336.
DOI: 10.1159/000526746.
Comparison of Breast Cancer and Cervical Cancer in Uzbekistan and Korea: The First Report of The Uzbekistan-Korea Oncology Consortium.
Rim C, Lee W, Musaev B, Volichevich T, Pazlitdinovich Z, Lee H
Medicina (Kaunas). 2022; 58(10).
PMID: 36295588
PMC: 9610191.
DOI: 10.3390/medicina58101428.
Ribociclib Plus Letrozole in Italian Male Patients with Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Case Studies of Phase 3b CompLEEment-1 Trial.
Caputo R, Fabi A, Romagnoli E, Baldini E, Grasso D, Fenderico N
Breast Cancer (Dove Med Press). 2022; 14:351-362.
PMID: 36267663
PMC: 9576937.
DOI: 10.2147/BCTT.S376902.
Comparison of Clinical, Pathological, and Prognostic Features in Mutant and Wild-Type Male Breast Cancer Patients.
Dogan I, Aydin E, Yazici H, Saip P
Eur J Breast Health. 2022; 18(4):323-328.
PMID: 36248747
PMC: 9521287.
DOI: 10.4274/ejbh.galenos.2022.2022-5-2.